HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dose regimen of favipiravir for Ebola virus disease.

AuthorsFrance Mentré, Anne-Marie Taburet, Jeremie Guedj, Xavier Anglaret, Sakoba Keïta, Xavier de Lamballerie, Denis Malvy
JournalThe Lancet. Infectious diseases (Lancet Infect Dis) Vol. 15 Issue 2 Pg. 150-1 (Feb 2015) ISSN: 1474-4457 [Electronic] United States
PMID25435054 (Publication Type: Letter)
Chemical References
  • Amides
  • Antiviral Agents
  • Pyrazines
  • favipiravir
Topics
  • Adult
  • Amides (administration & dosage, pharmacokinetics)
  • Animals
  • Antiviral Agents (administration & dosage, pharmacokinetics)
  • Computer Simulation
  • Ebolavirus (drug effects)
  • Hemorrhagic Fever, Ebola (drug therapy)
  • Humans
  • Mice
  • Models, Animal
  • Plasma (chemistry)
  • Pyrazines (administration & dosage, pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: